Evaluation of De-escalated Adjuvant Radiation Therapy for Human Papillomavirus (HPV)-Associated Oropharynx Cancer

NCT02908477 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

228

Enrollment

OTHER

Sponsor class

Conditions

Oropharynx Cancer

Interventions

RADIATION: Adjuvant Radiation Therapy
DRUG: Docetaxel
DRUG: Cisplatin

Sponsor

Mayo Clinic